An updated analysis of JULIET, a global pivotal phase 2 trial of tisagenlecleucel in adult patients with replapsed or refractory (r/r) diffuse large b cell lymphoma (DLBCL) EHA Library Borchmann P. 2018 Jun 16; 214521: S799. Im Internet - Borchmann, P; Tam, CS; Jäger, U